# Novanta to acquire Riverpoint Medical for $1.45B

Novanta Inc. entered a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion upfront plus a $250 million milestone payment in Q1 2027. The transaction is expected to close in Q3 2026.

- Type: Acquisition
- Announced: 2018-05-25
- Where: United States
- Value: $1.45B
- Status: announced
- Products: minimally invasive surgical consumables
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Arlington Capital Partners](https://endata.com/companies/20929.md) (partner)
- [Novanta](https://endata.com/companies/24684.md) (acquirer)
- [Riverpoint Medical](https://endata.com/companies/32149.md) (target)

## Sources

- [business.sherbrookerecord.com](https://business.sherbrookerecord.com/sherbrookerecord/article/bizwire-2026-6-9-novanta-inc-announces-acquisition-of-riverpoint-medical), 2018-05-25: "Novanta will acquire all outstanding equity interests of the parent company of Riverpoint Medical for an upfront cash consideration of $1.2 billion and a milestone payment of $250 million in the first quarter of 2027."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.